From The Medical Letter on Drugs and Therapeutics
March21, 2017
Article Information
JAMA. 2017;317(11):1171. doi:10.1001/jama.2016.17844
Full Text
The oral biguanide metformin (Glucophage, and others) is generally the drug of choice for initial treatment of type 2 diabetes. It has also been used to prevent or at least delay the onset of diabetes in patients considered to be at high risk for the disease. Recent guidelines recommend considering use of metformin in patients with prediabetes (fasting plasma glucose 100-125 mg/dL, 2-hr post-load glucose 140-199 mg/dL, or A1C 5.7-6.4%), especially in those who are <60 years old, have a BMI >35 kg/m2, or have a history of gestational diabetes.1 Metformin has not been approved for such use by the FDA.
Full Text
Add or change institution
Read More About
Citation
Metformin for Prediabetes. JAMA. 2017;317(11):1171. doi:10.1001/jama.2016.17844
Manage citations:
© 2024
Add or change institution